Home » Topics » BioWorld Science

BioWorld Science
RSS

Capricor initiates phase II HOPE-2 trial of CAP-1002 in Duchenne muscular dystrophy

May 2, 2018

FDA clears Pluristem's IND application for PLX-R18 to treat acute radiation syndrome

May 2, 2018

Exicure reports phase I data on AST-005 in plaque psoriasis

May 2, 2018

Aptevo submits IND for phase I study of APVO-436 in AML and MDS

May 2, 2018

Roche reflects on accomplishments of first quarter 2018

May 2, 2018

DCB discovers type III TKIs for cancer

May 2, 2018

AbbVie presents BRD4 inhibitors

May 2, 2018

FDA grants priority review to sBLA for Keytruda

May 2, 2018

Actelion seeks FDA approval of Opsumit for inoperable chronic thromboembolic pulmonary hypertension

May 2, 2018

FDA approves Tafinlar + Mekinist for adjuvant treatment of BRAF V600-mutant melanoma

May 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Novartis to pay $1.5B for Myricx Bio and its novel ADC payloads
BioWorld
Novartis AG is to pay $1.1 billion up front to acquire Myricx Bio Ltd., a preclinical-stage antibody-drug conjugate (ADC) specialist that is advancing a novel and...